Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06770036 · ClinicalTrials.gov registry record · NA
Caregiver Implementation Strategies Field Pre-Test
A NA study of Attention Deficit Hyperactivity Disorder Symptoms, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06770036: Completed NA study of Attention Deficit Hyperactivity Disorder Symptoms, sponsored by Children's Hospital of Philadelphia.
NCT06770036 is a NA study of Attention Deficit Hyperactivity Disorder Symptoms that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06770036, a NA study of Attention Deficit Hyperactivity Disorder Symptoms, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to field pre-test an implementation strategy resource package that aims to support caregivers in using behavioral interventions for children with hyperactive, inattentive, or impulsive behaviors. Enrolled caregivers will be assigned to use the resource package with their children. The research team will collect quantitative and qualitative data regarding acceptability, appropriateness, and feasibility, in preparation for a randomized pilot study.
Primary Outcome
Caregiver-reported total score on the Feasibility of Intervention Measure (FIM), which consists of 4 items on a 5-point Likert scale (from 1 = Completely Disagree to 5 = Completely Agree). The total score is the average of the 4 item scores.
Conditions Studied
Interventions
- BEHAVIORAL Implementation Resource Package for Caregivers
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-07-30 |
| Est. Completion | 2026-01-23 |
| Phase | NA |
What the finished NCT06770036 record still lists
NCT06770036 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Attention Deficit Hyperactivity Disorder Symptoms appearing as the primary indexed condition, and to 1 intervention - of which Implementation Resource Package for Caregivers is the first listed.
NCT06770036 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06770036 about?
NCT06770036 is a clinical study titled "Caregiver Implementation Strategies Field Pre-Test". The purpose of this study is to field pre-test an implementation strategy resource package that aims to support caregivers in using behavioral interventions for children with hyperactive, inattentive, or impulsive behaviors. Enrolled caregivers will be assigned to use the resource package with their...
What is the current status of trial NCT06770036?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2025-07-30. Estimated completion is 2026-01-23.
What conditions does trial NCT06770036 study?
This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder Symptoms.
What interventions are being tested in trial NCT06770036?
The interventions under investigation include: Implementation Resource Package for Caregivers (BEHAVIORAL).
Who is sponsoring clinical trial NCT06770036?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06770036 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06770036's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI